Date:Wednesday Dec 21, 2011
Title:Gene controlling melanoma spread identified
Abstract:Gene status can specify extent and location of metastases
Cancer information systems update (20.Dec.11)
NZ price of cancer report (20.Dec.11)
Indoor tanning and risk of early-onset basal cell carcinoma (19.Dec.11)
Impact of physician screening on melanoma detection (15.Dec.11)
HSC to launch new youth campaign (07.Dec.11)
Highlights from Melanoma International Congress (06.Dec.11)
MelaFind diagnostic tool (02.Dec.11)
Date:Friday Nov 25, 2011
Title:The melanomas: a heterogeneous group
Abstract:A comprehensive review article
Sunbeds, vitamin D and health (24.Nov.11)
International Melanoma Congress (23.Nov.11)
Mutant gene increases melanoma risk (21.Nov.11)
New “Sun Protection Alert” (18.Nov.11)
Counselling youth on prevention in primary care setting (15.Nov.11)
NSW Skin Cancer Prevention Strategy 2012–15 (10.Nov.11)
Opportunistic melanoma screening in New Zealand (09.Nov.11)
2-cm vs 4-cm excision margins for high-risk melanoma (03.Nov.11)
Control of skin cancer by the circadian rhythm (02.Nov.11)
View more Postings for November.
Date:Tuesday Oct 25, 2011
Title:Sharpened strategies for public health efforts in melanoma
Abstract:The most comprehensive report to date
US guidelines for primary cutaneous melanoma (23.Oct.11)
Combination therapy for head and neck skin cancers (22.Oct.11)
Update of NICE skin cancer/melanoma advice (21.Oct.11)
New melanoma genetic research findings (20.Oct.11)
SLN & metastases in children and adolescents (18.Oct.11)
Role of UVA in skin cancer (14.Oct.11)
California bans sunbeds for under 18’s (12.Oct.11)
Shift work and melanoma (10.Oct.11)
Clue to pigmented nodular melanoma (07.Oct.11)
View more Postings for October.
Beta-blockers and melanoma (27.Sep.11)
High incidence of NMSC in NZ (23.Sep.11)
Bill banning minors from tanning beds (22.Sep.11)
Clues to skin cancer metastases (19.Sep.11)
TNF Inhibitors for rheumatoid arthritis (15.Sep.11)
Frailty linked to outcome (14.Sep.11)
View more Postings for September.
Sentinel lymph node biopsy in head and neck melanoma (29.Aug.11)
Sun safety low priority for primary care (23.Aug.11)
Commerce Commission cautions sunbed industry over claims (22.Aug.11)
FDA approves vemurafenib (21.Aug.11)
Overcoming resistance to PLX4032 and GSK2118436 (09.Aug.11)
Australia New Zealand Therapeutic Products Agency (08.Aug.11)
View more Postings for August.
Comment sought on SPF 50+ Sunscreen for Australia/NZ (25.Jul.11)
Merkel Cell Carcinoma in WA (24.Jul.11)
Metastasis drivers in early-stage melanoma (24.Jul.11)
Long-term outcome of Spitz-type tumours (23.Jul.11)
Impact of physician screening on detection (22.Jul.11)
Limb infusion for advanced limb melanoma (21.Jul.11)
UK guidance for beauty therapists (29.Jun.11)
Aspirin and melanoma (28.Jun.11)
Shining a light on sunbeds (27.Jun.11)
Driver-side automobile UV exposure (26.Jun.11)
Gene alterations and melanoma risk (25.Jun.11)
Study calls for total body exam for suspicious lesions (20.Jun.11)
Call for comprehensive approach to prevention relevant to NZ (27.May.11)
Vaccine therapy for metastatic melanoma (23.May.11)
Outdoor sports and risk of UV-related skin lesions in children (20.May.11)
RNA spurs melanoma development (19.May.11)
Adolescents’ use of indoor tanning (17.May.11)
Noninvasive genomic detection of melanoma (16.May.11)
Plasma markers for metastatic melanoma (29.Apr.11)
Sunbed regulation in the UK (28.Apr.11)
ASCO targeted therapy finder for melanoma (27.Apr.11)
Lymphatic mapping and sentinel lymph node biopsy (19.Apr.11)
Adverse effects of UVR from indoor tanning (19.Apr.11)
Sun exposure before and after melanoma diagnosis (18.Apr.11)
Diagnostic imaging for melanoma (31.Mar.11)
Adding DNase1 to the anti-cancer toolbox (28.Mar.11)
Non-melanoma skin cancer (22.Mar.11)
Call for government action on sunbeds (10.Mar.11)
The good, the bad, and the ugly of sunscreens (04.Mar.11)
The indoor tanning industry’s double game (03.Mar.11)
Surgical Oncology Clinics of North America focus on melanoma (28.Feb.11)
Non-invasive genomic detection of melanoma (27.Feb.11)
Impact of melanoma on patients' lives (26.Feb.11)
Preliminary results of phase 3 RG7204 (PLX4032) trial (21.Feb.11)
Photodynamic therapy (PDT) and melanoma (20.Feb.11)
Australian study impacts on sunbed legislation (08.Feb.11)
View more Postings for February.
Melanoma thickness in NZ Europeans, Maori and Pacific (25.Jan.11)
Managing the skin cancer surge (24.Jan.11)
Non-melanoma skin cancers in New Zealand—a neglected problem (23.Jan.11)
Pathology referrals for skin lesions—are we giving the pathologist sufficient clinical information? (22.Jan.11)
UVR emissions from solaria in Australia and implications for the regulation process (17.Jan.11)
Prevalence and characteristics of indoor tanning use among men and women in the United States (16.Jan.11)